genetic molecular basis drug resistance species-specific drug action schistosome parasites
oxamniquine resistance evolved human blood fluke schistosoma mansoni brazil 1970s crossed parental parasites differing similar fold drug response determined drug sensitivity marker segregation clonally derived second-generation progeny identified single quantitative trait locus logarithm odds chromosome sulfotransferase identified causative gene using rna interference knockdown biochemical complementation assays subsequently demonstrated independent origins loss-of-function mutations field-derived laboratory-selected resistant parasites results demonstrate utility linkage mapping human helminth parasite crystallographic analyses protein-drug interactions illuminate mode drug action provide framework rational design oxamniquine derivatives kill s mansoni s haematobium two species responsible >% schistosomiasis cases worldwide
